Advantech iView 5.7.03.6112/5.7.03.6182/5.7.04.6469 cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.7 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in Advantech iView. This impacts an unknown function. Executing a manipulation can lead to cross site scripting. This vulnerability is tracked as CVE-2025-41442. The attack can be launched remotely. No exploit exists. It is advisable to upgrade the affected component.
Details
A vulnerability classified as problematic was found in Advantech iView. This vulnerability affects an unknown functionality. The manipulation with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. CVE summarizes:
A vulnerability exists in Advantech iView versions prior to 5.7.05 build 7057, which could allow a reflected cross-site scripting (XSS) attack. By manipulating certain input parameters, an attacker could execute unauthorized scripts in the user's browser, potentially leading to information disclosure or other malicious activities.
The weakness was disclosed by Alex Williams as icsa-25-191-08. The advisory is shared for download at cisa.gov. This vulnerability was named CVE-2025-41442 since 07/02/2025. The exploitation appears to be easy. The attack can be initiated remotely. No form of authentication is required for a successful exploitation. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
Upgrading to version 5.7.05 Build 7057 eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2025-21083). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.advantech.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.8VulDB Meta Temp Score: 4.7
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 5.4
CNA Vector (icscert): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: iView 5.7.05 Build 7057
Timeline
07/02/2025 CVE reserved07/11/2025 Advisory disclosed
07/11/2025 VulDB entry created
07/23/2025 VulDB entry last update
Sources
Vendor: advantech.comAdvisory: icsa-25-191-08
Researcher: Alex Williams
Status: Confirmed
CVE: CVE-2025-41442 (🔒)
GCVE (CVE): GCVE-0-2025-41442
GCVE (VulDB): GCVE-100-316072
EUVD: 🔒
Entry
Created: 07/11/2025 07:04Updated: 07/23/2025 23:01
Changes: 07/11/2025 07:04 (77), 07/11/2025 09:23 (1), 07/23/2025 23:01 (1)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.